We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPC icon
2826
Pilgrim's Pride
PPC
$6.56B
$1K ﹤0.01%
32
-1,751
-98% -$35.4K
PUI icon
2827
Invesco Dorsey Wright Utilities Momentum ETF
PUI
$54.2M
$1K ﹤0.01%
+35
New +$925
QMCO icon
2828
Quantum Corp
QMCO
$460M
$1K ﹤0.01%
+4
New +$575
RCKY icon
2829
Rocky Brands
RCKY
$372M
$1K ﹤0.01%
47
-226
-83% -$2.59K
REW icon
2830
Proshares UltraShort Technology
REW
$3.18M
0
RFFC icon
2831
ALPS Active Equity Opportunity ETF
RFFC
$30.7M
$1K ﹤0.01%
+31
New +$879
RIGS icon
2832
ALPS Strategic Income Fund
RIGS
$60.4M
$1K ﹤0.01%
+54
New +$1.36K
RKDA icon
2833
Arcadia Biosciences
RKDA
$1.56M
$1K ﹤0.01%
1
-19
-95% -$13.7K
RMD icon
2834
ResMed
RMD
$32.4B
$1K ﹤0.01%
11
-665
-98% -$46K
ROL icon
2835
Rollins
ROL
$17.7B
$1K ﹤0.01%
54
-1,514
-97% -$23.9K
RTC
2836
DELISTED
Baijiayun Group
RTC
$1K ﹤0.01%
+60
New +$878
RYAM icon
2837
Rayonier Advanced Materials
RYAM
$620M
$1K ﹤0.01%
+100
New +$1.4K
SBSI icon
2838
Southside Bancshares
SBSI
$974M
$1K ﹤0.01%
31
-720
-96% -$24.6K
SCNI
2839
Scinai Immunotherapeutics
SCNI
$1.34M
$1K ﹤0.01%
+1
New +$515
SEE
2840
DELISTED
Sealed Air
SEE
$1K ﹤0.01%
31
-3,285
-99% -$154K
SIF icon
2841
SIFCO Industries
SIF
$177M
$1K ﹤0.01%
159
+101
+174% +$826
SISI
2842
DELISTED
Shineco
SISI
0
DCOY
2843
Decoy Therapeutics
DCOY
$2.16M
0
SMLV icon
2844
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$261M
$1K ﹤0.01%
+13
New +$1.2K
SNV
2845
DELISTED
Synovus
SNV
$1K ﹤0.01%
16
-1,218
-99% -$50.8K
SPR
2846
DELISTED
Spirit AeroSystems
SPR
$1K ﹤0.01%
13
-214
-94% -$12.5K
SRTS icon
2847
Sensus Healthcare
SRTS
$49.1M
$1K ﹤0.01%
200
-800
-80% -$3.77K
SSBI icon
2848
Summit State Bank
SSBI
$90.1M
$1K ﹤0.01%
66
-70
-51% -$828
TCRT icon
2849
Alaunos Therapeutics
TCRT
$4.86M
$1K ﹤0.01%
1
-74
-99% -$68.9K
TGLS icon
2850
Tecnoglass Holdings Inc.
TGLS
$1.97B
$1K ﹤0.01%
+100
New +$1.16K

Similar funds

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.